newsfilter
← Latest News
Business Wire·

Robbins Arroyo LLP Is Investigating the Officers and Directors of Juniper Pharmaceuticals, Inc. on Behalf of Shareholders

SAN DIEGO & BOSTON--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Juniper Pharmaceuticals, Inc. (NASDAQGS: JNP) violated federal securities laws by issuing materially misleading information to the investing public. Juniper Pharmaceuticals focuses on developing therapeutics that address unmet medical needs in women's health.